- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05108441
Ultrasound and MRI Measurement of Quadriceps Femoris Muscle in Critically Ill Children (Echo-QF-IRM)
Comparison of Quadriceps Femoris Measurements in Critically Ill Children, Using Bedside Ultrasound and Magnetic Resonance Imaging
A vast majority of children admitted to paediatric intensive care (PICU) present with faltering growth during their admission. Muscle mass loss is an early, intense and frequent phenomenon in this setting, which is associated with impaired outcomes. Recent international guidelines recommend monitoring both nutritional status and muscle mass throughout hospital stay. Recent studies have used quadriceps femoris (QF) measurements as a surrogate for lean mass assessment, and monitored them with bedside ultrasound (QF thickness and QF cross sectional area). However, ultrasound cross sectional area inter-operator reproducibility has not been validated so far, and none of these ultrasound measurements has been validated against their gold standard i.e. magnetic resonance imaging measurements. This validation process should be conducted to allow interpreting ultrasound muscle measurements, prior to the implementation of ultrasound measurments into clinical practice.
We hypothesise that ultrasound measurements of QF thickness and cross sectional area are reliable compared to the magnetic resonance imaging gold standard, and that QF cross sectional area has a reliable inter-operator reproducibility.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: VALLA Frédéric, Pr
- Phone Number: +33 472 12 97 44
- Email: Frederic.valla@chu-lyon.fr
Study Contact Backup
- Name: BAUDIN Florent, Dr
- Phone Number: +33 472 12 97 35
- Email: Florent.baudin@chu-lyon.fr
Study Locations
-
-
-
Bron, France, 69500
- Recruiting
- Paediatric intensive care - Hospices Civils de Lyon
-
Contact:
- VALLA Frédéric, Pr
- Phone Number: +33 472 12 97 44
- Email: Frederic.valla@chu-lyon.fr
-
Contact:
- BAUDIN Florent, Dr
- Phone Number: +33 472 12 97 35
- Email: Florent.baudin@chu-lyon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- critically ill children from 0 to 17 years old
- magnetic resonance imaging planned for any medical reason
- sedated child for any medical reason
- absence of parental/patient refusal to participate to the study
Exclusion Criteria:
- congenital neuromuscular disease
- no possible access to the thigh (e.g. dressing, drains, gypsum)
- anatomical anomaly of the limb, that would compromise localizing thigh landmarks (patella, groin)
- inability to obtain limb rest and/or thigh muscle decontraction
- risk induced by mobilization of the patient for ultrasound or magnetic resonance imaging purpose
- absence of social insurance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Echo
Ultrasound and magnetic resonance imaging measurements of quadriceps femoris
|
In sedated critically ill children, quadriceps femoris thickness and cross sectional area will be measured with thigh bedside ultrasound, performed by two trained operators consecutively.
These two measurements will also be made at the exact same location on a magnetic resonance imaging transverse view of the thigh, to allow comparing them to ultrasound measurements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
intraclass correlation coefficient between ultrasound measurements and magnetic resonance imaging measurements
Time Frame: All ultrasound measurements will be made the same day than the magnetic resonance imaging, in a 6 hour-range prior or after the magnetic resonance imaging.
|
The mean of 4 measurements of quadriceps femoris thickness and the mean of 3 measurements of quadriceps femoris cross sectional area, performed by ultrasound, will be compared with the measurements means performed by magnetic resonance imaging
|
All ultrasound measurements will be made the same day than the magnetic resonance imaging, in a 6 hour-range prior or after the magnetic resonance imaging.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: VALLA Frédéric, Pr, Hospices Civils de Lyon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL21_1076
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ultrasound and magnetic resonance imaging measurements of quadriceps femoris
-
Mayo ClinicNational Cancer Institute (NCI)Enrolling by invitationAnatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Resectable Breast CarcinomaUnited States
-
Assiut UniversityUnknownKnee Cyst Popliteal (___Cm)
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Centre Antoine LacassagneCompleted
-
Ottawa Hospital Research InstituteWithdrawnFemoroacetabular Impingement
-
Assiut UniversityUnknown
-
University Hospital, CaenInstitut National de la Santé Et de la Recherche Médicale, France; Université... and other collaboratorsUnknownInhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders (SUPTOC)Healthy | Obsessive Compulsive DisorderFrance
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
Boston UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); US Department of...Terminated
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingType 2 Diabetes Mellitus | Cognitive ImpairmentChina